When.com Web Search

  1. Ads

    related to: respimat inhaler

Search results

  1. Results From The WOW.Com Content Network
  2. Respimat - Wikipedia

    en.wikipedia.org/wiki/Respimat

    Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its developer, Boehringer Ingelheim , is currently [ when? ] conducting approved in the U.S. with a variety of their products, such as tiotropium and ...

  3. Olodaterol - Wikipedia

    en.wikipedia.org/wiki/Olodaterol

    Olodaterol (trade name Striverdi Respimat) is an ultra-long-acting β adrenoreceptor agonist (ultra-LABA) used as an inhalation for treating people with chronic obstructive pulmonary disease (COPD). It is manufactured by Boehringer Ingelheim .

  4. How Much Does Stiolto Respimat Cost with Medicare?

    www.aol.com/lifestyle/much-does-stiolto-respimat...

    Cost of Stiolto Respimat with Medicare. As of June 1, 2024, companies like Boehringer Ingelheim and AstraZeneca placed an out-of-pocket price cap on their inhalers for COPD and asthma. For ...

  5. Tiotropium bromide - Wikipedia

    en.wikipedia.org/wiki/Tiotropium_bromide

    Tiotroprium is available in two inhaler formats: a soft mist inhaler (Respimat) and a dry powder inhaler (HandiHaler). [30] The safety and efficacy profiles of both devices are comparable and people's preference should play a role in determining inhaler choice. [ 30 ]

  6. Yes, the price of an inhaler in the US is massively ... - AOL

    www.aol.com/yes-price-inhaler-us-massively...

    One international pharmaceutical company charges $489 for brand name inhaler Combivent Respimat in the United States but just $7 in France.

  7. Some drugmakers to cap cost of asthma inhalers at $35 a month

    www.aol.com/news/drugmakers-cap-cost-asthma...

    Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.

  1. Ad

    related to: respimat inhaler